OC
IART icon

Oppenheimer & Co’s Integra LifeSciences IART Stock Holding History

Oppenheimer & Co’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5,726
Closed -$396K – 1536
2021
Q1 		$396K Sell
5,726
-2,878
-33% -$195K 0.01% 1060
2020
Q4 		$559K Buy
8,604
+685
+9% +$36.9K 0.01% 847
2020
Q3 		$374K Buy
7,919
+2,648
+50% +$126K 0.01% 909
2020
Q2 		$248K Buy
+5,271
New +$259K 0.01% 1032
2020
Q1 		– Sell
-7,841
Closed -$457K – 1253
2019
Q4 		$457K Buy
7,841
+211
+3% +$12.6K 0.01% 871
2019
Q3 		$458K Buy
7,630
+23
+0.3% +$1.37K 0.01% 823
2019
Q2 		$425K Sell
7,607
-110
-1% -$5.67K 0.01% 875
2019
Q1 		$430K Sell
7,717
-2,340
-23% -$119K 0.01% 887
2018
Q4 		$454K Buy
10,057
+153
+2% +$8.39K 0.01% 769
2018
Q3 		$652K Buy
9,904
+1,875
+23% +$117K 0.02% 754
2018
Q2 		$517K Buy
8,029
+1
+0% +$62 0.01% 847
2018
Q1 		$444K Sell
8,028
-1,800
-18% -$94.3K 0.01% 892
2017
Q4 		$470K Buy
9,828
+2,535
+35% +$124K 0.01% 879
2017
Q3 		$368K Buy
7,293
+1,466
+25% +$75.3K 0.01% 956
2017
Q2 		$318K Buy
+5,827
New +$278K 0.01% 1005
2013
Q4 		– Sell
-26,092
Closed -$429K – 1420
2013
Q3 		$429K Buy
26,092
+9,529
+58% +$153K 0.02% 814
2013
Q2 		$248K Buy
+16,563
New +$243K 0.01% 1009

Other funds holding IART

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EVM
Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Oppenheimer & Co's IART Position: Q2 2021 in Review

Oppenheimer & Co sold out of Integra LifeSciences (IART) in Q2 2021, closing a stake of 5,726 shares — an estimated $396K sold.

Oppenheimer & Co first reported a position in IART in Q2 2013 and held it in 17 quarters. The position peaked at $652K in Q3 2018. 264 funds tracked by Wall St. Rank hold IART as of Q2 2021.

  • Oppenheimer & Co reported no remaining Integra LifeSciences position as of Q2 2021 after selling out during the quarter.
  • Oppenheimer & Co sold 5,726 Integra LifeSciences shares in Q2 2021, an estimated $396K.
  • Oppenheimer & Co first reported a position in Integra LifeSciences in Q2 2013 and held it in 17 quarters.
  • Oppenheimer & Co's Integra LifeSciences position peaked at $652K in Q3 2018.
  • 264 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2021.

Based on Oppenheimer & Co's 13F filing for Q2 2021, filed 3 Aug 2021.